Wang, Luping
Schmidt, Sarah
Larsen, Petra P.
Meyer, Johanna H.
Roush, William R.
Latz, Eicke
Holz, Frank G.
Krohne, Tim U. http://orcid.org/0000-0003-2280-925X
Funding for this research was provided by:
China Scholarship Council (Luping Wang)
Ernst und Berta Grimmke Stiftung (Petra Larsen, Tim Krohne)
Deutsche Forschungsgemeinschaft (KR 2863/7-2)
Homann-Stiftung (Tim Krohne)
Dr. Eberhard und Hilde R?diger Foundation (Tim Krohne)
Article History
Received: 4 October 2018
Revised: 10 January 2019
Accepted: 29 January 2019
First Online: 10 February 2019
Compliance with ethical standards
:
: L. Wang, S. Schmidt, P. P. Larsen declare that they have no conflict of interest. J. H. Meyer declares support from Heidelberg Engineering. W. R. Roush is a shareholder and employee of IFM Therapeutics. E. Latz is a co-founder and consultant of IFM Therapeutics. F. G. Holz declares support from Acucela, Allergan, Bayer, Centervue, NightstarX, Novartis, Genentech/Roche, Heidelberg Engineering, Optos, and Carl Zeiss Meditec. T. U. Krohne declares support from Alimera Sciences, Bayer, Heidelberg Engineering, and Novartis.